Bonk (NASDAQ:BNKK) Director Mitchell Austin Rudy Acquires 11,659 Shares of Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy purchased 11,659 shares of Bonk stock in a transaction dated Thursday, July 2nd. The shares were bought at an average price of $1.47 per share, with a total value of $17,138.73. Following the completion of the transaction, the director owned 85,000 shares in the company, valued at approximately $124,950. This trade represents a 15.90% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Mitchell Austin Rudy also recently made the following trade(s):

• On Monday, June 22nd, Mitchell Austin Rudy purchased 7,500 shares of Bonk stock. The shares were purchased at an average cost of $1.56 per share, for a total transaction of $11,700.00.
• On Tuesday, June 16th, Mitchell Austin Rudy purchased 2,500 shares of Bonk stock. The stock was purchased at an average price of $1.32 per share, for a total transaction of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy acquired 12,000 shares of Bonk stock. The stock was purchased at an average cost of $1.37 per share, with a total value of $16,440.00.
• On Thursday, April 9th, Mitchell Austin Rudy acquired 31,055 shares of Bonk stock. The shares were purchased at an average cost of $2.82 per share, with a total value of $87,575.10.

Bonk Stock Performance

Shares of BNKK stock opened at $1.39 on Wednesday. The stock has a fifty day moving average price of $1.84 and a 200 day moving average price of $2.78. The stock has a market cap of $11.12 million, a PE ratio of -0.30 and a beta of 1.89. Bonk, Inc. has a 1 year low of $1.25 and a 1 year high of $46.90.

Bonk (NASDAQ:BNKK) last posted its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The firm had revenue of $0.79 million during the quarter.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on BNKK shares. Wall Street Zen upgraded shares of Bonk from a “sell” rating to a “hold” rating in a report on Saturday. Weiss Ratings downgraded shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

Institutional Trading of Bonk

A number of large investors have recently made changes to their positions in BNKK. State Street Corp purchased a new stake in Bonk during the 4th quarter worth about $33,000. Jane Street Group LLC acquired a new stake in shares of Bonk during the 4th quarter worth about $96,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk during the 4th quarter worth about $37,000. Finally, Geode Capital Management LLC purchased a new stake in shares of Bonk during the fourth quarter worth about $128,000. Institutional investors and hedge funds own 12.55% of the company’s stock.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.